Newsfeeds - Spark Newswire

1 minute read

News

Stealth BioTherapeutics Late Friday Announced It Received Nasdaq Notice That It Is Not In Compliance With Minimum Market Value Requirement; Co. Has til Aug. 10, 2022 To Regain Compliance

Today, 5:18 AM

Stealth BioTherapeutics Corp (NASDAQ:MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today

MITO

1 minute read

Stealth BioTherapeutics Announces Oral Presentation Of New Duchenne Muscular Dystrophy Data At 2022 Muscular Dystrophy Association Clinical And Scientific Conference

By Bill Haddad

Today, 5:18 AM

MITO

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s After-Market Session

By Benzinga Insights

Today, 5:18 AM

Gainers

BRTX

2 minute read

FDA
News

Stealth BioTherapeutics Reports Positive Pre-IND Meeting For Duchenne Muscular Dystrophy

By Benzinga Newsdesk

Today, 5:18 AM

MITO

1 minute read

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights

Today, 5:18 AM

ARNA

2 minute read

Movers

12 Health Care Stocks Moving In Friday’s After-Market Session

By Benzinga Insights

Today, 5:18 AM

Gainers

ATHX

10 minute read

Earnings Scheduled For November 11, 2021

By Benzinga Insights

Today, 5:18 AM

Companies Reporting Before The Bell • NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million.

ACHR

1 minute read

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights

Today, 5:18 AM

ACOR

1 minute read

Stealth Bio Stock Falls On FDA Refusal to File Letter For Barth Syndrome Candidate

By Vandana Singh

Today, 5:18 AM

Stealth BioTherapeutics Corp (NASDAQ:MITO) has received a Refusal to File letter from the FDA regarding its marketing application for elamipretide, a…

MITO

1 minute read

12 Health Care Stocks Moving In Wednesday’s Pre-Market Session

By Benzinga Insights

Today, 5:18 AM

ATIP